Biotech MavenHot Analyst Reads4 Hot Analyst Reads For Friday, June 29thBiotech MavenGalapagos -13% after AbbVie pulls out of cystic fibrosis development plansGalapagos (GLPG) -13.3% after-hours following news that AbbVie (ABBV) decided not to proceed with a study of a combination therapy for cystic fibrosis, andseekingalpha.com